ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,601
Screening encounters
1,699
Diagnostic referrals
321
Outstanding pathways
148

Screening pathway

  1. Screening1,699Encounters
  2. Positive finding566Documented findings
  3. Referral321Diagnostic referrals
  4. Follow-up340Diagnostic visits
  5. Outcome173Resolved pathways

Stage totals use different units. Pending pathways: 148. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3003 · EXP-3003Synthetic · Site C

Full participant history through 2025-10-18, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

No matching referral was available at this observation date.

Screened participants

1601 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1971 · Expanded synthetic participant 1971Site B — Peri-Urban Access Programme
EXP-1973 · Expanded synthetic participant 1973Site D — Community Engagement Programme
EXP-1975 · Expanded synthetic participant 1975Site C — Rural Outreach Programme
EXP-1977 · Expanded synthetic participant 1977Site A — Urban Referral Hub
EXP-1980 · Expanded synthetic participant 1980Site B — Peri-Urban Access Programme
EXP-1982 · Expanded synthetic participant 1982Site C — Rural Outreach Programme
EXP-1983 · Expanded synthetic participant 1983Site C — Rural Outreach Programme
EXP-1988 · Expanded synthetic participant 1988Site A — Urban Referral Hub
EXP-1994 · Expanded synthetic participant 1994Site D — Community Engagement Programme
EXP-1997 · Expanded synthetic participant 1997Site D — Community Engagement Programme
EXP-1998 · Expanded synthetic participant 1998Site D — Community Engagement Programme
EXP-2002 · Expanded synthetic participant 2002Site E — Resource-Constrained Navigation Programme
EXP-2006 · Expanded synthetic participant 2006Site B — Peri-Urban Access Programme
EXP-2008 · Expanded synthetic participant 2008Site B — Peri-Urban Access Programme
EXP-2009 · Expanded synthetic participant 2009Site B — Peri-Urban Access Programme
EXP-2016 · Expanded synthetic participant 2016Site B — Peri-Urban Access Programme
EXP-2020 · Expanded synthetic participant 2020Site E — Resource-Constrained Navigation Programme
EXP-2021 · Expanded synthetic participant 2021Site C — Rural Outreach Programme
EXP-2028 · Expanded synthetic participant 2028Site B — Peri-Urban Access Programme
EXP-2029 · Expanded synthetic participant 2029Site D — Community Engagement Programme
EXP-2034 · Expanded synthetic participant 2034Site B — Peri-Urban Access Programme
EXP-2035 · Expanded synthetic participant 2035Site C — Rural Outreach Programme
EXP-2037 · Expanded synthetic participant 2037Site B — Peri-Urban Access Programme
EXP-2047 · Expanded synthetic participant 2047Site B — Peri-Urban Access Programme
EXP-2049 · Expanded synthetic participant 2049Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
721
HPV DNA
734
Cytology
244

Navigation activity

Barrier documented
270
Contact attempt
468
Navigation intervention
112
Diagnostic booking
392
Diagnostic visit
340

Documented barriers

Contact difficulty
84
Transport difficulty
92
Appointment coordination
94

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.